Status:
UNKNOWN
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease
Lead Sponsor:
Ariel Dogliotti
Collaborating Sponsors:
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Coronaviruses are enveloped viruses with an RNA genome. Carrageenans are sulfate polysaccharides synthesized by red algae. Studies conducted in adults and children with the common cold showed the effe...
Detailed Description
This is a multicenter, randomized, double-blind, placebo-controlled trial assessing the use a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 disease in health-workers.
Eligibility Criteria
Inclusion
- physician, nurses, and physical therapist who usually attend hospitalized COVID19 patients.
- No more than 48 hours since he/she assisted a COVID-19 patient
- Able to understand and give written informed consent
Exclusion
- Participation in any other clinical trial of an experimental treatment for COVID-19
- Not having a cell phone with WhatsApp for remote monitoring
- Hypersensitivity or known allergy to any component of the product
- Pregnancy or lactation
Key Trial Info
Start Date :
July 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04521322
Start Date
July 24 2020
End Date
November 30 2020
Last Update
August 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
centro de educación médica e investigaciones clinicas (CEMIC)
Buenos Aires, Buenos Aires F.D., Argentina, 1425